Trial Profile
French real-life experience of add-on omalizumab in children with severe allergic asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2015
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 16 Oct 2015 New trial record